The Spatial Biology Week 2024 logo
October 14-18 | ONLINE
Join for the 4th edition and experience spatial biology in action.

ABOUT THE EVENT

about image

The Spatial Biology Week™ is a virtual event open to everyone, dedicated to exploring cutting-edge innovations across diverse research fields. Each day will focus on a different application, featuring talks from top experts followed by live Q&A sessions where you can engage directly with leading scientists.

This year we are partnering with the European Association for Cancer Research (EACR). Together, we will host an exclusive roundtable where leading experts discuss how spatial biology can drive innovation in cancer research and outline how it can be adopted.

Whether you're interested in attending a single session or the full week, this is a unique opportunity to gain valuable insights and expand your knowledge. Register now to secure your spot!

AGENDA

From Discovery to Therapy: Advancing Immuno-Oncology Research

Kick off the event with a day dedicated to the groundbreaking advancements powered by spatial biology in immuno-oncology, from basic to translational research. Learn about pioneering studies that are unraveling the mechanisms of immune responses in tumors and translating these findings into innovative therapies. Engage with leading scientists and researchers who are shaping the future of cancer treatment through precision immuno-oncology, driving patients closer to more effective and personalized cancer care.

Day two focuses on the innovative strides in the realms of neurosciences and neuro-oncology. Learn about the latest research unveiling the complexities of the brain and nervous system, and how spatial biology is driving discoveries in treating neurological disorders and brain tumors. Engage with experts as they share insights into the future of brain health and neuro-oncology.

Engage with the power of integrating multiple modalities in spatial biology. This day highlights the synergies of different technologies to gain a comprehensive understanding of biological systems. From multiomics to advanced imaging techniques, see how spatial multi-modalities are driving innovative research and leading to holistic insights into health and disease. Engage with pioneers who are at the forefront of this integrative approach, shaping the future of biomedical research.

This day is dedicated to exploring spatial biology's vast potential beyond immuno-oncology. From infectious to cardiovascular diseases, delve into the transformative research leveraging spatial biology to address a wide array of health challenges. Be inspired by innovative solutions and interdisciplinary collaborations that are pushing the boundaries of what is possible in medical sciences.

To conclude the event, the focus shifts to the pivotal role of image and data analysis in spatial biology. Discover how advanced imaging technologies and data analytics are unlocking new dimensions of biological understanding. Explore how cutting-edge computational tools are transforming data into actionable insights and learn about the latest innovations enhancing the precision and depth of biomedical research.

OUR SPEAKERS

Prof. Dr. Nigel Jamieson

Prof. Dr. Nigel Jamieson

Professor and Group Leader

Prof. Dr. Nigel Jamieson

Prof. Dr. Nigel Jamieson

Professor and Group Leader, University of Glasgow

Nigel Jamieson is a Clinical Senior Lecturer within the Institute of Cancer Sciences and an Honorary HPB surgeon at Glasgow Royal Infirmary. He completed his undergraduate medical degree at the University of Glasgow when his interest in pancreatic cancer research began. He subsequently undertook a PhD funded by the Chief Scientist Office investigating gene expression signatures in pancreatic adenocarcinoma at the Beatson Institute. After completing his surgical training including observership periods at Johns Hopkins, Baltimore and Memorial Sloan Kettering Cancer Center, New York he undertook an international fellowship year of pancreas and liver surgery in Royal North Shore Hospital, Sydney, Australia where he gained significant experience in post-neoadjuvant therapy pancreatic resections. Grants from the Academy of Sciences and Pancreatic Cancer UK maintained his research output during his surgical training. He was recently awarded a Clinician Scientist Fellowship by Cancer Research UK and upon returning to Glasgow was awarded a Lord Kelvin and Adam Smith Leadership Fellowship from the University of Glasgow.

He has contributed to over 70 peer reviewed publications and with an active role in the development and management of the Precision-Panc platform, his primary research interest now focusses upon the interaction between the genomic landscape, the immune microenvironment and chemotherapy in patients with pancreatic cancer. Specifically, he will look to develop combination therapeutic strategies that target Immune evasion in pancreatic cancer.

EACR Roundtable: Pioneering in the unknown: how to navigate through the spatial biology

Dr. Brian Piening

Dr. Brian Piening

Associate Member

Dr. Brian Piening

Dr. Brian Piening

Associate Member, Earle A Chiles Research Institute, Providence Health

Dr. Piening is the Technical Director for Clinical Genomics at Providence Health as well as Chief of the Cancer Immunogenomics Laboratory at the Earle A Chiles Research Institute at Providence. His work is focused on using multi-omics, imaging and computational approaches to deeply characterize clinical specimens to discern new insights into health and disease.

Strategies for spatial multi-omic profiling of histopathology tissues

Dr. Vytautas Navikas

Dr. Vytautas Navikas

Computer Vision Scientist

Dr. Vytautas Navikas

Dr. Vytautas Navikas

Computer Vision Scientist, Lunaphore

Vytautas has an extensive background in state-of-the-art imaging modalities and truly believes that seeing is believing. During his studies, he worked on developing and applying various cutting-edge single-cell imaging techniques ranging from scanning-probe microscopy to single-molecule localization microscopy. He graduated with a Ph.D. in Biotechnology and Bioengineering from Ecole Polytechnique Fédérale de Lausanne (EPFL) in 2021. Vytautas joined Lunaphore in 2022 and since then he has been working on bringing the analysis tools for multi-plex immunofluorescence images to accelerate the adoption of spatial biology.

Navigating the multiplex image analysis workflow: from images to data-driven insights

Dr. Karuna Ganesh

Dr. Karuna Ganesh

Director of Metastasis Research, Center for Colorectal Cancer

Dr. Karuna Ganesh

Dr. Karuna Ganesh

Director of Metastasis Research, Center for Colorectal Cancer, Memorial Sloan Kettering Cancer Center

Karuna Ganesh, MD, PhD, is a physician-scientist focused on investigating and treating metastatic gastrointestinal cancers at Memorial Sloan Kettering Cancer Center, New York, USA. She received her undergraduate and MD/PhD degrees from the University of Cambridge/MRC Laboratory of Molecular Biology, UK, where she studied mechanisms of antibody diversification with the late Professor Michael Neuberger. She trained in internal medicine at the Beth Israel Deaconess Medical Center/Harvard Medical School and in medical oncology at Memorial Sloan Kettering Cancer Center, where she completed a postdoctoral fellowship with Dr. Joan Massagué. Dr. Ganesh leads a research laboratory in the Molecular Pharmacology Program, is an Attending Physician in the Gastrointestinal Oncology Service, and Director of Metastasis Research in the Center for Colorectal Cancer at Memorial Sloan Kettering. The Ganesh laboratory employs (1) hypothesis-generation using transcriptomics, epigenomics and spatial/histological analysis of patient samples of primary and metastatic gastrointestinal (GI) cancer with (2) mechanistic dissection in cutting-edge patient-derived organoid models, including co-cultures with immune/stromal cells (3) genetically engineered and orthotopic transplantation models of metastatic GI cancer. By combining murine and clinically relevant patient-derived models, they seek to define the molecular mechanisms that underpin the phenotypic plasticity of metastatic cancer, and the co-evolution of the tumor microenvironmental response to dynamically emerging tumor regenerative states. The goal of the Ganesh laboratory is to identify crucial signaling nodes required for metastatic plasticity that can be therapeutically targeted to improve outcomes for patients with advanced cancer.

Dissecting plasticity during colorectal cancer progression

Dr. Kimberly Jordan

Dr. Kimberly Jordan

Research Associate Professor

Dr. Kimberly Jordan

Dr. Kimberly Jordan

Research Associate Professor, University of Colorado

As the co-founder of the Human Immune Monitoring Shared Resource (HIMSR) at the University of Colorado School of Medicine, I ensure the generation of high quality human translational research data in immunology. The HIMSR provides expertise in high parameter immunologic assays that interrogate liquid and tissue biopsies, including multiplex tissue imaging and spatial transcriptomics. I direct an impressive team of researchers with over 53 years of experience in multiplex IHC, histology, antibody optimization, and image analysis. My personal research interests continue to be in discovering the mechanisms of immune disfunction and in establishing rationale for clinical trials that aim to improve outcomes in patients.

Visualizing complex tissue microenvironments with high parameter spatial proteomics and transcriptomics

Dr. Denis Schapiro

Dr. Denis Schapiro

Managing Director, Translational Spatial Profiling Center (TSPC)

Dr. Denis Schapiro

Dr. Denis Schapiro

Managing Director, Translational Spatial Profiling Center (TSPC), Heidelberg University Hospital

Dr. Denis Schapiro is Managing Director of the Translational Spatial Profiling Center (TSPC) and Research Group Leader at the Heidelberg University Hospital focusing on spatial omics technologies and analysis.

Spatial omics of acute myocardial infarction reveals a novel mode of immune cell infiltration

Dr. Zahraa Rahal

Dr. Zahraa Rahal

Postdoctoral Research Fellow

Dr. Zahraa Rahal

Dr. Zahraa Rahal

Postdoctoral Research Fellow, University of Texas MD Anderson Cancer Center

Zahraa Rahal earned her medical degree from the American University of Beirut in Lebanon. She is currently a postdoctoral research fellow at UT MD Anderson Cancer Center, where she works under the guidance of Dr. Humam Kadara. Zahraa's research focuses on mapping the ecologic evolution of lung cancer at its earliest stages of development. She is interested in mapping epithelial and immune cues along the pathogenic continuum of normal lung tissue and up to lung adenocarcinoma. As an aspiring physician-scientist, she is dedicated to pushing the boundaries of cancer research and committing her career to serving patients with cancer.

A multimodal spatial-omics atlas of the course of non-malignant lung identifies proinflammatory and targetable cues that promote progression to lung adenocarcinoma.

Dr. Antonio L. Amelio

Dr. Antonio L. Amelio

Associate Professor and Vice Chair for Research in Head and Neck Oncology

Dr. Antonio L. Amelio

Dr. Antonio L. Amelio

Associate Professor and Vice Chair for Research in Head and Neck Oncology, H. Lee Moffitt Cancer Center & Research Institute

Dr. Antonio Amelio is the Vice Chair of Research in Head and Neck Oncology at the H. Lee Moffitt Cancer Center & Research Institute. He oversees the Amelio Lab within the Cancer Biology & Evolution Program, focusing on the molecular mechanisms behind tumor development and progression. His lab employs light-based technologies and bioinformatics to examine cell signaling, gene expression, and their impact on cancer cell behavior. Dr. Amelio's interdisciplinary research particularly targets adaptive stress signaling networks in oral and head and neck cancers, aiming to understand these pathways to inform future therapeutic interventions.

Mapping immune cell infiltration in an HPV+ OPC mouse model using spatial multiomics profiling

Dr. Danh Truong

Dr. Danh Truong

Instructor

Dr. Danh Truong

Dr. Danh Truong

Instructor, University of Texas MD Anderson Cancer Center

I study bone and soft tissue sarcoma at MD Anderson Cancer Center. Given over 100 different sarcoma subtypes, my range of scope is narrowed to desmoplastic small round cell tumors, Ewing sarcoma, and liposarcoma. To that end, my approach has been to comprehensively characterize these disease entities through a multi-modal omics approach using single-cell/nucleus RNA- and/or ATAC-sequencing, spatial transcriptomics/proteomics. Second, we aim to dissect biology and tumor microenvironment and determine signatures or drivers of tumorigenesis that could enable therapeutic targeted therapies. Third, instead of systemic cytotoxic therapies, we aim to propose methods to repair cancer cells. I am developing a mesenchymal stem cell differentiation model to determine the regulators that promote differentiation toward osteoblasts, myoblasts, and adipocytes. My hypothesis is that studying the regulators of differentiation can help us infer and target the error in differentiation amongst different sarcomas with possible mesenchymal origins.

Revealing the tumor heterogeneity of desmoplastic small round cell tumors through spatial analysis

Dr. Mark Youngblood

Dr. Mark Youngblood

Resident in Neurological Surgery

Dr. Mark Youngblood

Dr. Mark Youngblood

Resident in Neurological Surgery, Northwestern University

Mark Youngblood is currently a 6th year neurosurgery resident at Northwestern University, and is interested in using spatial and single-cell approaches to gain new insights on brain tumor biology and therapeutic vulnerabilities. He completed the MD/PhD program at Yale University under the guidance of Murat Gunel, where his thesis focused on epigenetic changes that underlie meningioma formation and tumor progression. He is currently completing an infolded clinical fellowship in skull base surgery, and working in the laboratory of Amy Heimberger to study the immunological features of meningiomas.

Spatial profiling to discover immuno-therapeutic targets in meningiomas

Dr. Irina Palacin Aliana

Dr. Irina Palacin Aliana

Postdoctoral Research Fellow

Dr. Irina Palacin Aliana

Dr. Irina Palacin Aliana

Postdoctoral Research Fellow, Northwestern University

Dr. Palacin is currently a postdoctoral fellow at Dr. Sita Lab at Northwestern University. She obtained her Biotechnology degree by the University of Vic, Barcelona, Spain in 2016 and her master’s degree by the San Pablo-CEU University, Madrid, Spain in 2017.

Assessing glioblastoma tumor dynamics and therapeutic impacts through Spatial Immunofluorescence

Prof. Dr. Katharina Imkeller

Prof. Dr. Katharina Imkeller

Professor

Prof. Dr. Katharina Imkeller

Prof. Dr. Katharina Imkeller

Professor, Goethe University Frankfurt

Prof. Dr. Katharina Imkeller is a renowned expert in the field of neuro-oncology and immunology, currently serving as a Professor for Translational Neurooncology and Quantitative Immunology at Goethe University Frankfurt since 2024. She leads a junior research group in Computational Immunology at the Mildred Scheel Early Career Center (MSNZ) Frankfurt, where her work focuses on integrating computational and experimental approaches to understand immune responses in cancer.

Glioma-associated tertiary lymphoid structures are sites of lymphocyte clonal expansion and plasma cell formation

Dr. Annie S. Li

Dr. Annie S. Li

Postdoctoral Fellow

Dr. Annie S. Li

Dr. Annie S. Li

Postdoctoral Fellow, Massachusetts General Hospital

Annie’s background as a physician-scientist provides a unique perspective to basic research and translation into the clinic. Her research interests lie in unraveling the complexity of the tumor microenvironment and immune landscape of cancers. She completed her MD at Heidelberg University and focused on investigating the role of the tumor microenvironment of pancreatic ductal adenocarcinoma in her graduate studies. After beginning her Postdoctoral Fellowship at MGH and HMS in 2023, she has been focused on investigating the biology of rare cancers such as adenoid cystic carcinoma and exploring new therapeutic approaches.

Immune landscape of adenoid cystic carcinoma: reversible downregulation of HLA class I

Dr. Akil Merchant

Dr. Akil Merchant

Director, Spatial Molecular Profiling Core

Dr. Akil Merchant

Dr. Akil Merchant

Director, Spatial Molecular Profiling Core, Cedars-Sinai, Cancer Institute

Dr. Merchant studies the interaction of cancer and the immune system. Most specifically he focuses on how the tumor microenvironment can drive the progression of cancer and promote resistance to treatments. He is an expert in spatial profiling of the tumor micrenvironment and he is the founding director of the Spatial Molecular Profiling core facility at Cedars Sinai Cancer. Dr. Merchant's clinical interests are in the care of patients with leukemia, lymphoma and other blood cancers. He is co-Director of the Lymphoma program and leads several clinical trials that offer novel therapies for patients with blood cancers. His ultimate goal is to better understand the immune response to cancer to better predict which patients will respond to treatment with immuno-oncology drugs and cellular therapies and to identify new immuno-oncology targets in the future.

Single cell spatial biomarkers in lymphoma

Prof. Dr. Roderick Beijersbergen

Prof. Dr. Roderick Beijersbergen

Group Leader

Prof. Dr. Roderick Beijersbergen

Prof. Dr. Roderick Beijersbergen

Group Leader , Netherlands Cancer Institute

Roderick Beijersbergen (PhD) is group leader at the Netherlands Cancer Institute, and professor Functional Genomics at the University of Amsterdam. His research focusses on the development and application of large-scale functional genomic technologies. His recent work uses advanced cell-based screening technologies allowing for the interrogation of spatial, dynamic and temporal phenotypes using high end microscopy. He is heading the NKI Robotics and Screening Center and the Genomics Core Facility in which high throughput screening, NGS, single cell and spatial transcriptomics. He is also part of the NKI virtual spatial omics core providing spatial analyses for both research and clinic.

EACR Roundtable: Pioneering in the unknown: how to navigate through the spatial biology

Prof. Dr. Jared K. Burks

Prof. Dr. Jared K. Burks

Professor and Co-Director of the North Campus Flow Cytometry & Cellular Imaging Core Facility

Prof. Dr. Jared K. Burks

Prof. Dr. Jared K. Burks

Professor and Co-Director of the North Campus Flow Cytometry & Cellular Imaging Core Facility, University of Texas MD Anderson Cancer Center

I started my carrier at Texas A&M University learning about patterns in genes and proteins, allowing and facilitating subcellular protein trafficking.  As I have progressed to MD Anderson Cancer Center, I have scaled to cellular trafficking attempting to understand the spatial distribution of cells in organ systems during disease.  As in many parts of life, form equals functions.  How our cells organize speaks to how they function and respond to their local environment.  Bringing together multi-omics approaches allows for greater clarity in these imaging snapshots that are collected. 

EACR Roundtable: Pioneering in the unknown: how to navigate through the spatial biology

Dr. Itay Tirosh

Dr. Itay Tirosh

Senior Scientist

Dr. Itay Tirosh

Dr. Itay Tirosh

Senior Scientist, Weizmann Institute of Science

Itay Tirosh obtained his PhD in computational biology at the lab of Naama Barkai, the Weizmann Institute of Science, Israel. From 2012 to 2017 he was a postdoctoral fellow at the Regev and Golub labs at the Broad Institute of MIT and Harvard, and since August 2017 he has been a Senior Scientist back at the Weizmann Institute of Science. The Tirosh lab is combining computational approaches and experimental single cell methods to understand the diversity of cells within human tumors, with a focus on glioma and head & neck cancer.

EACR Roundtable: Pioneering in the unknown: how to navigate through the spatial biology

Dr. Michaeline Bunting

Dr. Michaeline Bunting

Sr. Director, Product Management and Marketing Spatial, Spatial Biology Division

Dr. Michaeline Bunting

Dr. Michaeline Bunting

Sr. Director, Product Management and Marketing Spatial, Spatial Biology Division, Bio-Techne

Michaeline is the Sr. Director of Product Marketing in the Spatial Biology Division at BioTechne. She has over 20 years of experience in the life science industry leading product management, marketing, and research & development in multiplex biomarker analysis. Michaeline received her PhD in Biochemistry from the University of Utah, performing research in the areas of inflammatory disease and cancer.

Multiomic analysis of the brain environment with subcellular RNA and protein profiling

Secure your seat and see spatial biology in use.

FAQs

REGISTER NOW

Error: Please enter your first name.
Error: Please enter your last name.
This field is required.
This field is required.
This field is required.
This field is required.
This field is required.
This field is required.
This field is required.
Does your laboratory perform stainings of tissue samples?*
This field is required.
This field is required.